Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Department of Neurology, Zhenhai People's Hospital, Ningbo 315202, Zhejiang Province, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Apr 25;53(2):141-150. doi: 10.3724/zdxbyxb-2023-0425.
To explore the influence factors for futile recanalization following endovascular treatment (EVT) in patients with acute basilar artery occlusion (BAO).
Clinical data of patients with acute BAO, who underwent endovascular treatment within 24 h of onset from January 2017 to November 2022, were retrospectively analyzed. The futile recanalization was defined as modified thrombolysis in cerebral infarction (mTICI) grade ≥2b or 3 after successful reperfusion, but the modified Rankin Scale score >2 at 3 months after EVT. Binary logistic regression model was used to analyze the influencing factors of futile recanalization.
A total of 471 patients with a median age of 68 (57, 74) years were included and 68.9% were males, among whom 298 (63.27%) experienced futile recanalization. Multivariate analysis revealed that concomitant atrial fibrillation (=0.456, 95%: 0.282-0.737, <0.01), bridging thrombolysis (=0.640, 95%: 0.416-0.985, <0.05), achieving mTICI grade 3 (=0.554, 95%: 0.334-0.918, <0.05), arterial occlusive lesion (AOL) grade 3 (=0.521, 95%: 0.326-0.834, <0.01), and early postoperative statin therapy (=0.509, 95%: 0.273-0.948, <0.05) were protective factors for futile recanalization after EVT in acute BAO patients. High baseline National Institutes of Health Stroke Scale (NIHSS) score (=1.068, 95%: 1.049-1.087, <0.01), coexisting hypertension (=1.571, 95%: 1.017-2.427, <0.05), multiple retrieval attempts (=1.237, 95%: 1.029-1.488, <0.05) and postoperative hemorrhagic transformation (=8.497, 95%: 2.879-25.076, <0.01) were risk factors. For trial of ORG 10172 in acute stroke treatment (TOAST) classification, cardiogenic embolism (=0.321, 95%: 0.193-0.534, <0.01) and other types (=0.499, 95%: 0.260-0.961, <0.05) were related to lower incidence of futile recanalization.
The incidence of futile recanalization after EVT in patients with acute BAO is high. Bridging venous thrombolysis before operation and an early postoperative statin therapy may reduce the incidence of futile recanalization.
探讨急性基底动脉闭塞(BAO)患者血管内治疗(EVT)后无效再通的影响因素。
回顾性分析 2017 年 1 月至 2022 年 11 月发病 24 h 内接受 EVT 的急性 BAO 患者的临床资料。无效再通定义为成功再通后改良脑梗死溶栓(mTICI)分级≥2b 或 3,但 EVT 后 3 个月改良 Rankin 量表评分>2。采用二元逻辑回归模型分析无效再通的影响因素。
共纳入 471 例患者,中位年龄为 68(57,74)岁,68.9%为男性,其中 298 例(63.27%)发生无效再通。多因素分析显示,伴发心房颤动(OR=0.456,95%:0.282-0.737,<0.01)、桥接溶栓(OR=0.640,95%:0.416-0.985,<0.05)、达到 mTICI 分级 3(OR=0.554,95%:0.334-0.918,<0.05)、动脉闭塞病变(AOL)分级 3(OR=0.521,95%:0.326-0.834,<0.01)和术后早期他汀类药物治疗(OR=0.509,95%:0.273-0.948,<0.05)是急性 BAO 患者 EVT 后无效再通的保护因素。基线国立卫生研究院卒中量表(NIHSS)评分较高(OR=1.068,95%:1.049-1.087,<0.01)、伴发高血压(OR=1.571,95%:1.017-2.427,<0.05)、多次取栓尝试(OR=1.237,95%:1.029-1.488,<0.05)和术后出血性转化(OR=8.497,95%:2.879-25.076,<0.01)是风险因素。对于急性卒中治疗试验组织 10172 试验(TOAST)分类,心源性栓塞(OR=0.321,95%:0.193-0.534,<0.01)和其他类型(OR=0.499,95%:0.260-0.961,<0.05)与无效再通发生率较低相关。
急性 BAO 患者 EVT 后无效再通发生率较高。术前桥接静脉溶栓和术后早期他汀类药物治疗可能降低无效再通的发生率。